Reducing bleeding during heart surgery with a special filter
Part of Heart & circulation clinical trials.
This study tests a special filter (called Cytosorb) that may reduce bleeding during heart surgery by capturing the blood thinner ticagrelor from your blood. If you take ticagrelor and are scheduled for heart surgery with a bypass machine, this filter could help lower your risk of bleeding.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have taken the blood thinner ticagrelor within the last 48 hours.
- You are having heart surgery that requires a heart-lung (bypass) machine.
- You are not taking other blood thinners or antiplatelet drugs (except aspirin and heparin).
- You do not have a serious infection, such as endocarditis, and are not on certain antibiotics, antifungals, or seizure medications that could be removed by the study filter.
- Women who can become pregnant must use effective birth control and have a negative pregnancy test.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial surveys surgeons about how they use hemostatic agents (medications that stop bleeding during surgery). It aims to understand current practices and improve patient safety.
This trial tests a device that filters the blood during urgent heart surgery. It may help patients who take blood thinners by reducing bleeding risks during surgery.
This trial tests whether giving back a patient's own platelets and red blood cells during heart surgery can reduce bleeding and the need for donor blood transfusions. It is for people having certain types of high-risk heart surgery with a heart-lung machine.
This trial tests two medicines—ACT (a blood thinner) and tranexamic acid (a medicine to reduce bleeding)—to see which is better at controlling bleeding during heart surgery. It is for adults having planned heart surgery with a heart-lung machine.
This trial tests whether collecting and re-infusing your own blood during heart surgery reduces the need for donor blood transfusions. It's for adults having planned bypass surgery with a heart-lung machine.
This study compares two ways of giving a medicine called tranexamic acid — as a pill or through an IV — to see which works better at reducing bleeding during heart bypass surgery. If you are having heart surgery without a heart-lung machine, this trial may help you recover with less bleeding.
Hear when a new Cardiac Surgery trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.